Loading clinical trials...

Benefit Evaluation of Foot Reflexology in Oncology | Clinical Trials | Clareo Health

COMPLETEDNA

Benefit Evaluation of Foot Reflexology in Oncology

Randomized Study Assessing the Benefits of Foot Reflexology in Patients With Gastrointestinal or Thoracic Cancer With Chemotherapy

NCT03508180•Hospices Civils de Lyon

View on ClinicalTrials.gov

Summary

Chemotherapy with platinum salts is very emetic. The aim of this study is to evaluate the benefits of foot reflexology in nausea and vomiting induced by platinum salts-based chemotherapy in patients with thoracic or digestive tumors.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patient with a thoracic or digestive cancer with indication of management with platinum salts-based chemotherapy
•Good performance status of (ECOG 0-2)
•More than 18 years old
•Ability to complete the questionnaires (comprehension oral and written French language) and to carry out the required exercises.
•Patient affiliated to Social Security or equivalent
•Informed consent signed

Exclusion Criteria

•Phlebitis
•Cellar syndrome
•Weight loss\> 5% in 3 months
•Uncontrolled pain
•Patients under morphine and derivatives
•Brain metastases
•Patient benefiting from foot reflexology outside the study
•Patient under guardianship or curatorship or deprived of his rights

Locations (1)

Centre Hospitalier Lyon Sud

Pierre-Bénite, France

Key Dates

Start Date

June 14, 2018

Primary Completion Date

February 3, 2020

Completion Date

April 8, 2020

Last Updated

December 19, 2025

Enrollment

ACTUAL participants

Conditions

Lung Cancer and Cancer of Digestive System

Interventions

INTERVIONNAL

BEHAVIORAL

CONTROL

OTHER